Value-based healthcare focuses on maximizing patient health outcomes through quality care and valuable interventions, enabling effective targeting of investments and promoting healthcare sustainability. We believe key measures to advance value-based healthcare include EU-wide Joint Clinical Assessments, improved alignment of data requirements, and innovative funding models.
Access hurdles, such as delays in patient access to innovative medicines, should be addressed through these measures. Johnson & Johnson supports value-based healthcare as a means to sustain and improve health outcomes for all patients across disease areas and emphasizes the importance of a structured dialogue among stakeholders to explore solutions and enhance patient access.